ReviewMolecular cancer2018

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.

Shaocong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.